WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Lung Cancer efficacy endpoints v6m, -cough -shortness of breath -chest pain -fatigue -other specifying severity, Karnofsky with allowed values 0, 10, 20...100, Lesion has type New lesion, Therapeutic Efficacy Endpoint is intersection of Therapeutic Intervention, Short axis for target lymph nodes measured in mm, Progression free survival (PFS) derived from Tumor Response, New lesion identified by Anatomical region, Informational or proposed for removal concepts identified by grey color boxes, Tumor Response assesses Lesion, LD (axial plane) for target lesion measured in mm, Qualitative Assessment have response options -Complete Response (CR) -Non-CR/non-PD -Not evaluated -Not all evaluated -Non-PD -PD -Unequivocal PD -Any, immunohistochemistry ???? target, Sum of longest diameters (SLD) has component LD (axial plane) for target lesion, - PD ???? Date of tumor progression, Concepts are denoted by solid round-edged rectangle, Anatomical region instantiated by -Lung -CNS (brain, leptomeninges) -Bone -Liver -Adrenal (L, R) -Mediastinum (anterior, middle, posterior) -Hilar (L, R) -Plural Fluid, OVERALL RESPONSE have response options - PD, LUNG CANCER EFFICACY ENDPOINTS include Time to progression of cancer symptoms, New lesion identified by Organ specific lesion ID, - CR - PR differentiated into Unconfirmed Response